LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 100 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,085,027 | -54.3% | 1,912,869 | -4.1% | 0.04% | -50.6% |
| Q2 2023 | $4,565,406 | -3.2% | 1,993,627 | +2.8% | 0.08% | -17.7% |
| Q1 2023 | $4,714,744 | +27.7% | 1,940,224 | +0.4% | 0.10% | +20.0% |
| Q4 2022 | $3,691,604 | -24.3% | 1,932,777 | -4.8% | 0.08% | -28.6% |
| Q3 2022 | $4,875,000 | +25.5% | 2,031,207 | -2.7% | 0.11% | +31.8% |
| Q2 2022 | $3,883,000 | -11.3% | 2,087,463 | -0.3% | 0.08% | +10.4% |
| Q1 2022 | $4,377,000 | -47.8% | 2,094,294 | -1.6% | 0.08% | -46.9% |
| Q4 2021 | $8,383,000 | -16.9% | 2,127,662 | +1.4% | 0.14% | -22.0% |
| Q3 2021 | $10,090,000 | +0.3% | 2,097,647 | -4.3% | 0.19% | +2.2% |
| Q2 2021 | $10,056,000 | -20.9% | 2,190,782 | +1.1% | 0.18% | -25.1% |
| Q1 2021 | $12,721,000 | +100.8% | 2,167,172 | +17.0% | 0.24% | +88.4% |
| Q4 2020 | $6,335,000 | +1167.0% | 1,852,382 | +433.4% | 0.13% | +975.0% |
| Q3 2020 | $500,000 | -30.1% | 347,260 | -3.1% | 0.01% | -33.3% |
| Q2 2020 | $715,000 | +2.9% | 358,510 | +0.6% | 0.02% | -14.3% |
| Q1 2020 | $695,000 | -58.1% | 356,345 | -10.8% | 0.02% | -41.7% |
| Q4 2019 | $1,657,000 | +16.8% | 399,374 | -15.3% | 0.04% | +9.1% |
| Q3 2019 | $1,419,000 | -55.8% | 471,349 | -7.7% | 0.03% | -56.0% |
| Q2 2019 | $3,213,000 | +5.0% | 510,834 | -7.2% | 0.08% | +8.7% |
| Q1 2019 | $3,061,000 | -14.8% | 550,549 | +1.8% | 0.07% | -25.8% |
| Q4 2018 | $3,592,000 | -41.8% | 540,934 | -6.5% | 0.09% | -27.3% |
| Q3 2018 | $6,175,000 | -23.7% | 578,719 | -14.2% | 0.13% | -23.4% |
| Q2 2018 | $8,098,000 | +19.5% | 674,825 | -14.7% | 0.17% | +25.6% |
| Q1 2018 | $6,776,000 | -19.7% | 790,685 | -7.4% | 0.13% | -17.9% |
| Q4 2017 | $8,439,000 | -23.5% | 854,175 | -4.8% | 0.16% | -20.2% |
| Q3 2017 | $11,025,000 | -6.2% | 897,045 | +25.5% | 0.20% | -10.2% |
| Q2 2017 | $11,759,000 | – | 714,830 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $34,786,000 | 99.98% |
| Artal Group S.A. | 57,517,978 | $463,019,000 | 19.93% |
| MASTERS CAPITAL MANAGEMENT LLC | 1,129,708 | $9,094,000 | 0.30% |
| Rhenman & Partners Asset Management AB | 170,915 | $1,376,000 | 0.16% |
| Round Table Services, LLC | 21,611 | $174,000 | 0.14% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $287,000 | 0.10% |
| FALCON POINT CAPITAL, LLC | 37,039 | $298,000 | 0.10% |
| SABBY MANAGEMENT, LLC | 318,775 | $2,566,000 | 0.09% |
| WILLIAM HARRIS INVESTORS INC | 39,495 | $318,000 | 0.09% |
| HOWARD HUGHES MEDICAL INSTITUTE | 51,520 | $415,000 | 0.09% |